START was a noninferiority randomized controlled trial testing accelerated steroid tapering among adults with steroid-sensitive podocytopathies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results